GLP-1 / metabolic
5-Amino-1MQ
Preclinical (animal)5-amino-1-methylquinolinium · NNMT inhibitor (small molecule)
Preclinical NNMT inhibitor marketed for fat loss without human data.
What it is
A small-molecule inhibitor of the enzyme NNMT (overexpressed in obese fat), promoted for metabolism and fat loss.
How it works
Inhibits NNMT to raise cellular NAD+/SAM and increase adipocyte energy expenditure, theoretically reducing fat storage.
Studied for
Obesity/fat loss and metabolic health (mechanistic/animal).
Regulatory status
Not FDA-approved; research chemical.
Safety
Human safety unestablished; no controlled trial data; product purity unverified.
What the community reports about 5-Amino-1MQ
Aggregated from real community discussions across social platforms and forums. Anecdotal and self-reported — not causal, not medical advice.
The NNMT inhibitor that "unblocks NAD+" by preventing its degradation in fat cells — distinct from AOD-9604 (which mobilizes fat directly), uploader generally prefers AOD for most patients but 5-Amino-1MQ pairs well in cellular-metabolism + NAD-pool support stacks.
Aggregated from public discussions and community forums, synthesized into themes and counts. Anecdotal and self-reported — not causal, not evidence a compound is safe or effective, not medical advice, and not a recommendation to use. No dosing shown.
Educational information only — not medical advice, and not a recommendation to use any compound. Many peptides here are not approved for human use; legal status and evidence quality vary and are noted above. This page contains no dosing information. Consult a qualified clinician before making any health decision.